These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1416574)
1. Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial. Bennish ML; Salam MA; Khan WA; Khan AM Ann Intern Med; 1992 Nov; 117(9):727-34. PubMed ID: 1416574 [TBL] [Abstract][Full Text] [Related]
2. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Khan WA; Seas C; Dhar U; Salam MA; Bennish ML Ann Intern Med; 1997 May; 126(9):697-703. PubMed ID: 9139555 [TBL] [Abstract][Full Text] [Related]
3. Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children. Zimbabwe, Bangladesh, South Africa (Zimbasa) Dysentery Study Group Pediatr Infect Dis J; 2002 Dec; 21(12):1136-41. PubMed ID: 12488664 [TBL] [Abstract][Full Text] [Related]
4. Treatment of shigellosis: IV. Cefixime is ineffective in shigellosis in adults. Salam MA; Seas C; Khan WA; Bennish ML Ann Intern Med; 1995 Oct; 123(7):505-8. PubMed ID: 7661494 [TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin and loperamide in the treatment of bacillary dysentery. Murphy GS; Bodhidatta L; Echeverria P; Tansuphaswadikul S; Hoge CW; Imlarp S; Tamura K Ann Intern Med; 1993 Apr; 118(8):582-6. PubMed ID: 8452323 [TBL] [Abstract][Full Text] [Related]
13. Single-dose ciprofloxacin for shigellosis in adults. Bhattacharya SK; Bhattacharya MK; Dutta D; Dutta P; Paul M; Sen D; Sarkar S; Saha A; Pal SC J Infect; 1992 Jul; 25(1):117-9. PubMed ID: 1522320 [No Abstract] [Full Text] [Related]
14. A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children. Vinh H; Anh VT; Anh ND; Campbell JI; Hoang NV; Nga TV; Nhu NT; Minh PV; Thuy CT; Duy PT; Phuong le T; Loan HT; Chinh MT; Thao NT; Tham NT; Mong BL; Bay PV; Day JN; Dolecek C; Lan NP; Diep TS; Farrar JJ; Chau NV; Wolbers M; Baker S PLoS Negl Trop Dis; 2011 Aug; 5(8):e1264. PubMed ID: 21829747 [TBL] [Abstract][Full Text] [Related]
15. [Ciprofloxacin in the treatment of dysentery caused by type 1 Shigella dysenteriae during an epidemic in Rwandan refugees in Goma in 1994]. Laureillard D; Paquet C; Malvy D Sante; 1998; 8(4):303-5. PubMed ID: 9794043 [TBL] [Abstract][Full Text] [Related]
16. Enteric protein loss during shigellosis. Bennish ML; Salam MA; Wahed MA Am J Gastroenterol; 1993 Jan; 88(1):53-7. PubMed ID: 8420274 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of Shigella flexneri and S. dysenteriae isolated from stool specimens of patients with bloody diarrhoea in Mwanza, Tanzania. Temu MM; Kaatano GM; Miyaye ND; Buhalata SN; Shushu ML; Kishamawe C; Changalucha JM Tanzan Health Res Bull; 2007 Sep; 9(3):186-9. PubMed ID: 18087897 [TBL] [Abstract][Full Text] [Related]
18. Multiple drug-resistant Shigella dysenteriae type 1 in Rajbari district, Bangladesh. Jahan Y; Hossain A J Diarrhoeal Dis Res; 1997 Mar; 15(1):17-20. PubMed ID: 9308296 [TBL] [Abstract][Full Text] [Related]
19. Comparative efficacies of single intravenous doses of ceftriaxone and ampicillin for shigellosis in a placebo-controlled trial. Kabir I; Butler T; Khanam A Antimicrob Agents Chemother; 1986 Apr; 29(4):645-8. PubMed ID: 3518625 [TBL] [Abstract][Full Text] [Related]
20. Re-emergence of multi-drug resistant Shigella dysenteriae with added resistance to ciprofloxacin in north India & their plasmid profiles. Taneja N; Lyngdoh V; Vermani A; Mohan B; Rao P; Singh M; Dogra A; Singh MP; Sharma M Indian J Med Res; 2005 Oct; 122(4):348-54. PubMed ID: 16394329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]